Drug makers hold negative view on drug re-categorization

Published: 2011-08-30 07:00:00
Updated: 2011-08-30 07:00:00
Pharmaceutical companies expressed a negative view toward the idea of re-categorizing medicines as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.

The reaction came after the Korea Food and Drug Association (KFDA) Monday announced it h...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.